OBJECTIVES: Co-administration of artemether/lumefantrine with antiretroviral therapy has potential for pharmacokinetic drug interactions. We investigated drug-drug interactions between artemether/lumefantrine and efavirenz or nevirapine. METHODS: We performed a cross-over study in which HIV-infected adults received standard six-dose artemether/lumefantrine 80/480 mg before and at efavirenz or nevirapine steady state. Artemether, dihydroartemisinin, lumefantrine, efavirenz and nevirapine plasma concentrations were measured and compared. RESULTS: Efavirenz significantly reduced artemether maximum concentration (C(max)) and plasma AUC (median 29 versus 12 ng/mL, P < 0.01, and 119 versus 25 ng · h/mL, P < 0.01), dihydroartemisinin C(max) and AU...
There is an increased recognition of the need to identify and quantify the impact of genetic polymor...
Treating malaria in HIV-coinfected individuals should consider potential drug-drug interactions. Art...
BACKGROUNDThe antiretroviral drug nevirapine and the antimalarial artemisinin-based combination ther...
OBJECTIVES: Co-administration of artemether/lumefantrine with antiretroviral therapy has potential f...
Artemether-lumefantrine and nevirapine-based antiretroviral therapy (ART) are the most commonly reco...
AIM: Drug-drug interactions between antimalarial and antiretroviral drugs may influence antimalarial...
Artemether-lumefantrine and nevirapine-based antiretroviral therapy (ART) are the most commonly rec-...
Artemether-lumefantrine and nevirapine-based antiretroviral therapy (ART) are the most commonly rec-...
Background: Treatment of HIV/malaria-coinfected patients with antiretroviral therapy (ART) and artem...
There is conflicting evidence of the impact of commonly used antiretroviral therapies (ARTs) on the ...
OBJECTIVES: Antimalarial combination therapy is used in persons with HIV infection in the absence of...
Treating malaria in HIV-coinfected individuals should consider potential drug-drug interactions. Art...
Treating malaria in HIV-coinfected individuals should consider potential drug-drug interactions. Art...
Background: HIV-malaria co-infected patients in most parts of sub-Saharan Africa are treated with bo...
There is an increased recognition of the need to identify and quantify the impact of genetic polymor...
There is an increased recognition of the need to identify and quantify the impact of genetic polymor...
Treating malaria in HIV-coinfected individuals should consider potential drug-drug interactions. Art...
BACKGROUNDThe antiretroviral drug nevirapine and the antimalarial artemisinin-based combination ther...
OBJECTIVES: Co-administration of artemether/lumefantrine with antiretroviral therapy has potential f...
Artemether-lumefantrine and nevirapine-based antiretroviral therapy (ART) are the most commonly reco...
AIM: Drug-drug interactions between antimalarial and antiretroviral drugs may influence antimalarial...
Artemether-lumefantrine and nevirapine-based antiretroviral therapy (ART) are the most commonly rec-...
Artemether-lumefantrine and nevirapine-based antiretroviral therapy (ART) are the most commonly rec-...
Background: Treatment of HIV/malaria-coinfected patients with antiretroviral therapy (ART) and artem...
There is conflicting evidence of the impact of commonly used antiretroviral therapies (ARTs) on the ...
OBJECTIVES: Antimalarial combination therapy is used in persons with HIV infection in the absence of...
Treating malaria in HIV-coinfected individuals should consider potential drug-drug interactions. Art...
Treating malaria in HIV-coinfected individuals should consider potential drug-drug interactions. Art...
Background: HIV-malaria co-infected patients in most parts of sub-Saharan Africa are treated with bo...
There is an increased recognition of the need to identify and quantify the impact of genetic polymor...
There is an increased recognition of the need to identify and quantify the impact of genetic polymor...
Treating malaria in HIV-coinfected individuals should consider potential drug-drug interactions. Art...
BACKGROUNDThe antiretroviral drug nevirapine and the antimalarial artemisinin-based combination ther...